Infectious agents in arthritis and autoimmunity

Modern Rheumatology

Volumn 13, Issue 2, 2003, Pages 97-102

  Victorio Navarra, Sandra ^a  

^a UNIVERSITY OF SANTO TOMAS   (Philippines)

Author keywords

Arthritis; Autoimmunity; Infection

Indexed keywords

ALPHA INTERFERON; HLA B27 ANTIGEN; RIBAVIRIN;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYME DISEASE; MOLECULAR MIMICRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; TREATMENT PLANNING; VIRUS INFECTION;

EID: 0042673985     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.3109/s01007-003-0206-x     Document Type: Review

References (115)

1. Krause A, Kamradt T, Burmester GR. Potential infectious agents in the induction of arthritides. Curr Opin Rheumatol 1996;8:203-9.
2. Rose NR. The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 1998;10:5-13.
3. Horwitz MS, Sarvetnick N. Viruses, host responses and autoimmunity. Immunol Rev 1999;169:241-53.
4. Panoutsakopoulou V, Cantor H. On the relationship between viral infection and autoimmunity. J Autoimmun 2001;16:341-5.
5. Fujinami RS. Viruses and autoimmune disease - two sides of the same coin? Trends Microbiol 2001;9:377-81.
6. Di Rosa F, Barnaba V. Persisting viruses and chronic inflammation: understanding their relation to autoimmunity. Immunol Rev 1998;164:17-27.
7. Shi FD, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol 2001;22:97-101.
8. Pacheco-Tena C, Zhang X, Stone M, Burgos-Vargas R, Inman RD. Innate immunity in host-microbial interactions: beyond B27 in the spondyloarthropathies. Curr Opin Rheumatol 2002;14:373-82.
9. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun 2001;16:175-86.
10. Albert LJ, Zhao Y-X, Inman RD. Molecular mimicry. In: Lahita RG, Chiorazzi N, Reeves WH, editors. Textbook of the autoimmune diseases. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 153-74.
11. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-20.
12. Gianani R, Sarvetnick N. Viruses, cytokines, antigens and autoimmunity. Proc Natl Acad Sci USA 1996;93:2257-9.
13. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983;2:824-6.
14. Naides SJ. Postinfectious autoimmunity. In: Lahita RG, Chiorazzi N, Reeves WH, editors. Textbook of the autoimmune diseases. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 693-708.
15. Crow MK. Superantigens. In: Lahita RG, Chiorazzi N, Reeves WH, editors. Textbook of the autoimmune diseases. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 19-35.
16. Schiffenbauer J, Soos J, Johnson H. The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 1998;19:117-20.
17. Schwab JH, Brown RR, Anderle SK, Schlievert PM. Superantigen can reactivate bacterial wall-induced arthritis. J Immunol 1993;150:4151-9.
18. Sigal LH. Update on reactive arthritis. Bull Rheum Dis 2001; 50:1-4.
19. Schumacher HR. Reactive arthritis. Rheum Dis Clin N Am 1998;24:261-73.
20. Kohler L, Zeidler H, Hudson AP. Etiologic agents in reactive arthritis: their molecular biology and phagocyte-host interactions. Baillieres Clin Rheumatol 1998;12:589-609.
21. Avakian H, Welsh J, Ebringer A, Entwistle CC. Ankylosing spondylitis, HLA-B27 and Klebsiella: Cross-reactivity studies with human tissue typing sera. Br J Exp Pathol 1980;61:92-6.
22. McGonagle D, Emery P. Enthesitis, osteitis, microbes, biomechanics, and immune reactivity in ankylosing spondylitis. J Rheumatol 2000;27:2302-4.
23. McGonagle D, Stockwin L, Isaacs J, Emery P. An enthesis based model for the pathogenesis of spondyloarthropathy: additive effects of microbial adjuvant and biomechanical factors at disease sites. J Rheumatol 2001;28:2155-9.
24. Pacheco-Tena C, Alvarado DLB, Lopez-Vidal Y, Vazquez-Mellado J, Richaud-Patin Y, Amieva RI, et al. Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology 2001;40:920-7.
25. Gladman DD. Current concepts in psoriatic arthritis. Curr Opin Rheumatol 2002;14:361-6.
26. Prinz JC. Psoriasis vulgaris: a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol 2001;26:326-32.
27. Baeten D, De Keyser F, Mielants H, Veys EM. Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol 2002;14:342-7.
28. De Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 2000;27:2860-5.
29. Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med 2000;11:210-4.
30. Bernstein CN, Blanchard JF, Rawesthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;96:1116-22.
31. Lionetti P, Pupi A, Veltroni M, et al. Evidence of subclinical intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27 positive juvenile onset active spondyloarthropathy. J Rheumatol 2000;27:1538-41.
32. Huelsemann JL, Zeidler H. Undifferentiated arthritis in an early synovitis out-patient clinic. Clin Exp Rheumatol 1995;13:37-43.
33. Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 1993;20:2005-9.
34. Hitchon CA, El-Gabalawy HS. Immune features of seronegative and seropositive arthritis in early synovitis studies. Curr Opin Rheumatol 2002;14:348-53.
35. Aggarwal A, Misra R, Chandrasekhar S, Prasad KN, Dayal R, Ayyagari A. Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis? Br J Rheumatol 1997;36:1001-4.
36. Schnarr S, Putschky N, Jendro MC, Zeidler H, Hammer M, Kuipers JG, et al. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis. Arthritis Rheum 2001;44:2679-85.
37. Gerard HC, Wang Z, Wang GF, El-Gabalawy H, Goldbach-Mansky R, Li Y, et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum 2001;44:1689-97.
38. Lopez de Castro JA. The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 1998;10:59-66.
39. Grantors K. Host-microbe interaction in reactive arthritis: does HLA-B27 have a direct effect? J Rheumatol 1998;25:1659-61.
40. Turner MJ, Colbert RA. HLA-B27 and pathogenesis of spondyloarthropathies. Curr Opin Rheumatol 2002;14:367-72.
41. Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S, et al. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 1992;19:1236-42.
42. Rynes RI, Goldenberg DL, DiGiacomo R, Olson R, Hussain M, Veazy J. Acquired immunodeficiency syndrome - associated arthritis. Am J Med 1988;84:810-6.
43. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000;30:147-66.
44. Kaye BR. Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Ann Intern Med 1989;111:158-67.
45. Rowe JF, Forster SM, Sefert MH. Rheumatological lesions in individuals with human immunodeficiency virus infection. Q J Med 1989;73:1167-84.
46. Drevlow BE, Schilling EM, Khabbaz RF, Kaplan JE, Fukuda K, Sinacore J, et al. Retroviral risk factors in patients with autoimmune disease. J Rheumatol 1996;23:428-31.
47. Berman A, Cahn P, Perez H, Spindler A, Lucero E, Paz S, et al. Prevalence and characteristics of rheumatic manifestations in patients infected with human immunodeficiency virus undergoing antiretroviral therapy [letter]. J Rheumatol 1997;24:2492.
48. Ayoub EM, Majeed HA. Poststreptococcal reactive arthritis. Curr Opin Rheumatol 2000;12:306-10.
49. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 1986;135:272-4.
50. Hammadeh MY, Dutta SN, Worrall JG, Morgan RJ. Acute reactive polyarthritis after intravesical bacillus Calmette-Guerin instillation. Br J Urol 1995;76:811-2.
51. Pancaldi P, Van Linthoudt D, Alborino D, Haefliger JM, Ou H. Reiter's syndrome after intravesical BCG treatment for superficial bladder carcinoma. Br J Rheumatol 1993;32:1096-8.
52. Hughes RA, Allard SA, Maini RN. Arthritis associated with adjuvant mycobacterial treatment for carcinoma of bladder. Ann Rheum Dis 1989;48:432-4.
53. Miossec P. Reactive arthritis associated with bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens [letter]. J Rheumatol 1996;23:1485.
54. Buchs N, Chevrel G, Miossec P. Bacillus Calmette-Guerin induced aseptic arthritis: an experimental model of reactive arthritis. J Rheumatol 1998;25:1662-5.
55. Gaston JHS, Life PF, Jenner PJ, Colston MJ, Bacon PA. Recognition of a mycobacteria-specific epitope in the 65-kD heat shock protein by synovial fluid-derived T cell clones. J Exp Med 1990;171:831-41.
56. Steere AC. Lyme disease. N Engl J Med 2001;345:115-25.
57. Weyand CA, Goronzy JJ. Immune responses to Borrelia burgdorferi in patients with reactive arthritis. Arthritis Rheum 1989;32:1057-64.
58. Arnett F. The Lyme spirochete: another cause of Reiter's syndrome? Arthritis Rheum 1989;32:1182-4.
59. Guerao-de-Arellano M, Huber BT. Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol 2002;14:388-93.
60. Weinstein A, Britchkov M. Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 2002;14:383-7.
61. Alspaugh MA, Tan EM. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen: demonstration by precipitation and immunofluorescence. Arthritis Rheum 1976;19:711-9.
62. Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA 1979;76:5825-8.
63. Ferrell PB, Aitcheson CT, Pearson GR, Tan EM. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest 1981;67:681-7.
64. Sculley TB, Walker PJ, Moss DJ, Pope JH. Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J Virol 1984;52:88-93.
65. Alspaugh MA, Henle G, Lennette ET, Henle W. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 1981; 67:1134-40.
66. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1218-25.
67. Blaschke S, Schwarz G, Moneke D, Binder L, Muller G, Reuss-Borst M. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 2000;27:866-73.
68. Sawada S, Takei M. Epstein-Barr virus and rheumatoid arthritis [letter]. J Rheumatol 2001;28:2363.
69. Hamerman D, Gresser I, Smith C. Isolation of cytomegalovirus from synovial cells of a patient with rheumatoid arthritis. J Rheumatol 1982;9:658-64.
70. Einsele H, Steidle M, Muller CA, Fritz P, Zacher J, Schmidt H, et al. Demonstration of cytomegalovirus DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis. J Rheumatol 1992;19:677-81.
71. Tamm A, Ziegler T, Lautenschlager I, Nikkari S, Mottonen T, Luukkainen R, et al. Detection of cytomegalovirus DNA in cells from synovial fluid and peripheral blood of patients with early rheumatoid arthritis. J Rheumatol 1993;20:1489-93.
72. Mousavi-Jazi M, Bostrom L, Lovmark C, Linde A, Brytting M, Sundqvist VA. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol 1998;25:623-8.
73. Brand A, Griffiths DJ, Herve C, Mallon E, Venables PJ. Human retrovirus-5 in rheumatic disease. J Autoimmun 1999;13:149-54.
74. Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996;23:979-83.
75. Olhagen B, Mansson I. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med Scand 1968;184:395-402.
76. Gripenberg M. Common serological features in rheumatoid arthritis and Yersinia arthritis. Demonstration of rheumatoid factors and antibodies against DNA and Yersinia enterocolitica lipopolysaccharide by ELISA. Scand J Rheumatol 1981;10:85-91.
77. Ebringer A, Ptaszynska T, Corbett M, Wilson C, Macafee Y, Avakian H, et al. Antibodies to Proteus in rheumatoid arthritis. Lancet 1985;2305-7.
78. Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J, et al. The susceptibility sequence to rheumatoid arthritis is a cross reactive B cell epitope shared by Escherichia coli heat shock protein DNA and the histocompatibility leucocyte antigen DRB10401 molecule. J Clin Invest 1992;89:327-31.
79. Hsu HC, Zhang HG, Song GG, Xie J, Liu D, Yang PA, et al. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection. Arthritis Rheum 2001;44:2146-59.
80. Ebringer A, Wilson C, Tiwana H. Is rheumatoid arthritis a form of reactive arthritis? J Rheumatol 2000;27:559-62.
81. Albert LJ. Infection and rheumatoid arthritis: guilt by association? J Rheumatol 2000;27:564-6.
82. Wilson C, Tiwana H, Ebringer A. Molecular mimicry between HLA-DR alleles associated with rheumatoid arthritis and Proteus mirabilis as the aetiological basis for autoimmunity. Microbes Infect 2000;2:1489-96.
83. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin Arthritis Rheum 1998;27:263-71.
84. James JA, Harley JB, Scofield RH. Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr Opin Rheumatol 2001;13:370-6.
85. James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44: 1122-6.
86. Nesher G, Osborn TG, Moore TL. Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995;24:297-303.
87. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol 1996;23:1180-5.
88. Moore TL, Bandlamudi R, Alam SM, Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin Arthritis Rheum 1999;28:314-8.
89. Kok RHJ, Wolfhagen JHM, Klosters G. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin Infect Dis 2001;32:311-2.
90. 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. J Rheumatol 2001;28:2335-6.
91. Fernandez-Miranda C, Rubio R, Pulido F. Development of acquired immune deficiency syndrome in a patient with systemic lupus erythematosus. J Rheumatol 1995;22:347-50.
92. Kopelman RH, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomenon. Am J Med 1988;84:82-8.
93. Gold J, Haubenstock A, Zalusky R. Lupus anticoagulant and AIDS. N Engl J Med 1986;314:1252-3.
94. Stimmler M, Quismorio F, McGehee W, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 1989;149:1833-5.
95. Savige JA, Chang L, Crowe SM. Antinuclear, antineutrophil cytoplasmic and antiglomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994;18:205-11.
96. Adelman MK, Marchalonis JJ. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol 2002;102:107-16.
97. Ronnblom L, Alm GV. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol 2001;22:427-31.
98. Bankhurst AD. Interferons and systemic lupus erythematosus. J Rheumatol 1987;13:63-7.
99. Guillevin L, Lhote F, Cohen P. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltim) 1995;74:238-53.
100. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217-25.
101. Schoenfeld Y, Sherer Y, Harats D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001;22:293-5.
102. Wagner AD, Gerard HC, Fresemann T, Schmidt WA, Gromnica-Ihle E, Hudson AP, et al. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000;43:1543-51.
103. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002;14:3-10.
104. Perez C, Loza E, Tinture T. Giant cell arteritis after influenza vaccination. Arch Intern Med 2000;160:2677.
105. Aggarwal A, Chag M, Sinha N, Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65kDa heat shock protein. Int J Cardiol 1997;55:49-55.
106. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
107. Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
108. Wener MH, Johnson RJ, Sasso EH, Gretch DR. Hepatitis C virus and rheumatic disease. J Rheumatol 1996;23:953-9.
109. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
110. Tepper JL, Feinman SV, D'Costa L, Sooknannan R, Pruzanski W. Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia. J Rheumatol 1998;25:925-8.
111. Ramos-Casals M, Cervera R, Yague J, Garcia-Carrasco M, Trejo O, Jimenez S, et al. Cryoglobulinemia in primary Sjogren's syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 1998;28:200-5.
112. Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, Cohen P, et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 2001;44: 2118-24.
113. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001;33: 240-7.
114. Cacoub P, Costedat-Chalumeau, Lidove O, Alric L. Cryoglobulinemia vasculitis. Curr Opin Rheumatol 2002;14:29-35.
115. Herath MG. Obstacles to identifying viruses that cause autoimmune disease. J Neuroimmunol 2000;107:154-60.